Q4 2022 Heidelberg Pharma AG Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining Heidelberg Pharma's conference call to discuss 2022 fiscal year results and provide a business update. (Operator Instructions) Please note that today's call is being recorded. The presentation will be followed by a Q&A session where you may ask written or audio questions. Please note that you can ask questions only online.
I would now like to turn the call over to Dr. Jan Schmidt-Brand, CEO and CFO. Please go ahead, Jan.
Good afternoon, ladies and gentlemen, and welcome to the Heidelberg Pharma conference call to discuss our 2022 fiscal year results and provide a business update. My name is Jan Schmidt-Brand, and I am the CEO and CFO of the company. Joining me on this call is my colleague, Professor Andreas Pahl, Chief Scientific Officer; and Katja Arnold, our Investor Relations consultant.
Please note that this presentation is available for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |